Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- 10 Kinds of Advanced Medical Treatment Services Approved
May 14, 2001
- CSTP Subpanel to Propose Promotion Strategy in Prioritized Fields
May 7, 2001
- OTC NEWS IN BRIEF
May 7, 2001
- PMSB Asks Manufacturers to Stop Supply of Phenacetin
May 7, 2001
- AstraZeneca's Diprivan Inj-Kit to Contribute to Preventing Accidents
May 7, 2001
- REGULATORY NEWS IN BRIEF
May 7, 2001
- Atorvastatin Raises Treatment Target Achievement Rates: Yamanouchi/Pfizer Seminar
May 7, 2001
- Japanese Global Strategy Update (1)
May 7, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -1-
May 7, 2001
- Pricing Rule for Innovative Medical Devices to Be Studied
May 7, 2001
- DIAGNOSTIC NEWS IN BRIEF
May 7, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -3-
May 7, 2001
- GPMSP Guidelines for Medical Devices to Go into Effect in October
May 7, 2001
- Takara Shuzo's Dragon Genomics Starts Full Operation
May 7, 2001
- WORLD NEWS IN BRIEF
May 7, 2001
- MEDICAL DEVICE NEWS IN BRIEF
May 7, 2001
- Chugai Establishes Chugai Pharma France in Paris
May 7, 2001
- Identification of Genes Related to Medical Diseases Expected within 10 Years
May 7, 2001
- BULLETIN
May 7, 2001
- MTP to Independently Market Grtpa
May 7, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…